BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27559941)

  • 21. [Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Liu J; Wu YJ; Guo X; Qiao C; Qiu HR; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):289-95. PubMed ID: 23628018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.
    Corrente F; Bellesi S; Metafuni E; Puggioni PL; Marietti S; Ciminello AM; Za T; Sorà F; Fianchi L; Sica S; De Stefano V; Chiusolo P
    Cytometry B Clin Cytom; 2018 May; 94(3):468-476. PubMed ID: 29220871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Your dilemma, my identity: unusual immunogenetic profiles of pediatric B cell acute lymphoblastic leukemia.
    Gupta A; Goyal M; Nidamanuri KR; Dattatreya PS
    Indian J Pathol Microbiol; 2014; 57(1):78-80. PubMed ID: 24739837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
    Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
    van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
    Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations.
    Re GG; Estrov Z; Antoun GR; Felix EA; Pinkel DP; Zipf TF
    Blood; 1991 Aug; 78(3):575-80. PubMed ID: 1713508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/.
    Kalff A; Juneja S
    Leuk Lymphoma; 2009 Apr; 50(4):523-4. PubMed ID: 19373647
    [No Abstract]   [Full Text] [Related]  

  • 29. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
    Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
    Boldt DH; Kopecky KJ; Head D; Gehly G; Radich JP; Appelbaum FR
    Leukemia; 1994 Dec; 8(12):2118-26. PubMed ID: 7807999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of CD22 expression and expansion of a CD22
    Reinert J; Beitzen-Heineke A; Wethmar K; Stelljes M; Fiedler W; Schwartz S
    Ann Hematol; 2021 Nov; 100(11):2727-2732. PubMed ID: 34331563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].
    Ma J; Liu YF; Chen SM; Zhang QT; Sun L; Liu LX; Wan DM; Chen SQ; Xie XS; Meng XL; Jiang ZX; Cheng YD; Wang F; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):942-5. PubMed ID: 20723305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
    Piccaluga PP; Malagola M; Rondoni M; Amabile M; Paolini S; Soverini S; Gaitani S; Visani G; Baccarani M; Martinelli G
    Eur J Haematol; 2004 Apr; 72(4):302-3. PubMed ID: 15089772
    [No Abstract]   [Full Text] [Related]  

  • 36. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
    Pane F; Cimino G; Izzo B; Camera A; Vitale A; Quintarelli C; Picardi M; Specchia G; Mancini M; Cuneo A; Mecucci C; Martinelli G; Saglio G; Rotoli B; Mandelli F; Salvatore F; Foà R;
    Leukemia; 2005 Apr; 19(4):628-35. PubMed ID: 15744351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
    Nakamura A; Tsurusawa M; Kato A; Taga T; Hatae Y; Miyake M; Mimaya J; Onodera N; Watanabe A; Watanabe T; Kanegane H; Matsushita T; Iwai A; Hyakuna N; Gushi K; Kawakami T; Sekine I; Izichi O; Asami K; Kikuta A; Tanaka A; Fujimoto T;
    Leuk Lymphoma; 2001 Jul; 42(3):393-8. PubMed ID: 11699404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
    Šálek C; Folber F; Froňková E; Procházka B; Marinov I; Cetkovský P; Mayer J; Doubek M;
    Eur J Haematol; 2016 Mar; 96(3):276-84. PubMed ID: 25997106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.